Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0428
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire? ; volume:53 ; number:1 ; day:6 ; month:11 ; year:2009 ; pages:1-6 ; date:1.2010
Diabetologia ; 53, Heft 1 (6.11.2009), 1-6, 1.2010
- Creator
-
Butler, P. C.
Matveyenko, A. V.
Dry, S.
Bhushan, A.
Elashoff, R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-009-1591-5
- URN
-
urn:nbn:de:101:1-2023050421052226073004
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Butler, P. C.
- Matveyenko, A. V.
- Dry, S.
- Bhushan, A.
- Elashoff, R.
- SpringerLink (Online service)
Other Objects (12)
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Innocent bystanders: how foreign uncertainty shocks harm exporters
Innocent bystanders? Monetary policy and inequality in the US
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Vascular Calcification: from Innocent Bystander to Culprit Risk Factor
Candida Pneumonia: An Innocent Bystander or a Silent Killer?
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Corrigendum: FGF23 in Cardiovascular Disease : Innocent Bystander or Active Mediator?
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Innocent bystanders: how foreign uncertainty shocks harm exporters
Innocent bystanders? Monetary policy and inequality in the US
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Vascular Calcification: from Innocent Bystander to Culprit Risk Factor
Candida Pneumonia: An Innocent Bystander or a Silent Killer?
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Corrigendum: FGF23 in Cardiovascular Disease : Innocent Bystander or Active Mediator?
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Innocent bystanders: how foreign uncertainty shocks harm exporters
Innocent bystanders? Monetary policy and inequality in the US
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Vascular Calcification: from Innocent Bystander to Culprit Risk Factor
Candida Pneumonia: An Innocent Bystander or a Silent Killer?
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Corrigendum: FGF23 in Cardiovascular Disease : Innocent Bystander or Active Mediator?